Alcami Corporation, a contract development and manufacturing organization (CDMO), appointed Jamie Iudica Chief Manufacturing Officer.

Iudica brings more than 25 years of experience in the pharmaceutical industry, including leadership roles in engineering, manufacturing, and supply chain operations.

Prior to joining Alcami, Iudica was chief manufacturing officer at Istari Oncology.

Iudica served in multiple manufacturing and operations leadership roles throughout his career including executive roles at Xellia Pharmaceuticals, Pfizer, and Hospira.

“Jamie’s extensive expertise in drug product manufacturing operations will be integral as we expand the Alcami manufacturing and operations footprint,” said Patrick Walsh, Chairman and CEO at Alcami Corporation.

Iudica is replacing outgoing chief operations officer Ken Domagalski, who is retiring at the end of the year.

As chief manufacturing officer, Iudica will assume Domagalski’s responsibilities for Alcami’s extensive drug product manufacturing operations that provide clinical to commercial sterile and oral solid dose development and manufacturing services.